Volume 11 • Issue 1 • January 2017
ISSN 1814 3601
Figure 1. Distribution of confirmed measles cases with rash onset 1–31 December 2016, WHO Western Pacific Region
Legend: No confirmed case With confirmed case No case based data Dots are placed at random within the corresponding district, and might not reflect the exact location of the case
DISCLAIMER: The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved *Map of Australia is from the Australian Bureau of Statistics
Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 January 2017
Table 1. Confirmed measles cases by month of rash onset, January–December 2016, WHO Western Pacific Region Country/area Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region 2016 Jan 6 0 2 1366 0 0 1 0 214 544 1 0 6 0 1 7 0 2148 Feb 15 0 0 2270 0 0 2 0 231 947 5 0 4 2 5 4 1 3486 Mar 16 0 0 4663 0 0 2 0 195 767 2 0 20 2 10 4 1 5682 Apr 10 0 0 5247 1 0 0 0 179 598 20 0 7 1 18 3 1 6085 May 5 0 2 3923 2 0 3 0 145 378 37 0 6 0 31 3 1 4536 Jun 4 0 4 2619 2 0 3 0 110 78 29 0 3 0 6 3 1 2862 Jul 6 0 5 1695 0 0 5 0 67 22 5 0 3 0 3 6 0 1817 Aug 1 1 11 866 0 0 76 0 101 4 3 0 4 1 8 3 0 1079 Sep 7 0 1 350 1 0 43 0 85 2 1 0 6 8 7 1 0 512 Oct 7 0 9 208 0 0 10 0 77 2 1 0 8 4 11 2 0 339 Nov 7 0 12 222 0 0 2 0 57 2 0 0 4 0 24 0 0 330 Dec 11 0 10 660 3 0 5 0 32 3 0 0 3 0 16 0 0 743
Source: Case based and aggregate data reports to the Western Pacific Regional Office by 20 January 2017
Figure 2. Confirmed measles cases by month of rash onset, WHO Western Pacific Region, 2010–2016 as of 20 January 2017 16 000
14 000
12 000
10 000 Number of measles cases
8 000
6 000
4 000
2 000
Source: Measles and rubella monthly country reports to WHO by 20 January 2017 Includes laboratory confirmed, epi-linked and clinically confirmed cases for 2010–2012
Country/area
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Total
Source: Measles and rubella monthly country reports to WHO by 20 January 2017
2
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2010 2011 2012 2013 2014 2015 2016
0
China
Philippines
Viet Nam
Malaysia
Papua New Guinea
Others
Table 2. Status of measles verification, WHO Western Pacific Region 2015 Year No. of cases 2014 2015 2015 2016 2014 2015 2014 74 4 0 41 217 12 0 32 56 1 302 1 617 13 53 688 7 39 291 20 45 425 Imported 33 1 0 3 16 0 2 0 0 0 0 3 9 0 0 67 Source of infection Importrelated 30 3 0 0 10 0 0 1 616 0 0 0 1 1 0 0 1 661 Unknown/ not reported 11 0 41 217 9 6 56 516 1 13 53 688 3 29 291 20 42 913 % of c ases w ith
2016 No. of confirmed cases 95 1 56 24 089 9 0 152 0 1 493 3 347 104 0 74 18 140 36 5 29 619 No measles cases ≥80% 60–79% <60% Imported 28 1 0 0 1 27 4 0 0 1 9 16 0 0 87 Source of infection Importrelated 15 0 0 0 0 97 0 3 338 0 0 9 90 0 0 3 549 Unknown / not reported 52 0 56 24 089 8 28 437 3 104 53 0 34 36 5 24 905 % of c ases w ith know n
verified confirmed
Endemic sourc e of infec tion
know n
Endemic sourc e of infec tion
0 0 0 0 0 0 617 0 0 0 0 0 0 0 0 617
85.1% 100.0% 0.0% 25.0% 81.3% 0.0% 47.5% 99.9% 0.0% 0.0% 0.0% 57.1% 25.6% 0.0% 0.0% 5.2% Blue Green Yellow Red
0 0 0 0 0 0 1 052 6 0 20 0 0 0 0 1 078
45.3% 100.0% 0.0% 0.0% 11.1% 81.6% 70.7% 99.9% 0.0% 28.4% 100.0% 75.7% 0.0% 0.0% 15.9%
Table 3. Measles case classification and incidence by country and area, WHO Western Pacific Region, 2012 —2016 as of 20 January 2017 2012 Measles incidence per 1 million pop. Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region 1 2 3 4 5
2013 Measles incidence per 1 million pop. 8.7 2.4 0.0 4.6 1.1 1.8 1.8 5.6 63.7 0.0 12.3 0.0 15.9 0.0 7.6 5.9 0.0 5.9 154 0 0 26912 34 3 141 68 177 0 9 7 3777 107 56 895 0 32 340 6.6 0.0 0.0 19.8 4.7 5.2 1.1 10.5 5.9 0.0 2.0 1.0 38.5 2.2 10.6 9.9 0.0 17.7
2014 Measles incidence per 1 million pop. 340 0 0 48 123 46 1 434 70 213 0 263 2 589 23 708 442 134 12 223 273 88 859 14.5 0.0 0.0 35.3 6.3 1.7 3.4 10.7 7.0 0.0 57.7 345.9 237.6 9.0 25.1 133.5 83.4 48.3
2015 Measles incidence Population Suspected (in per measles 1 million pop. 74 4 0 41 217 12 0 32 56 1 302 1 617 13 53 688 7 39 291 20 45 425 3.3 9.0 0.0 29.5 1.6 0.0 0.3 8.0 43.3 566.4 2.9 6.9 6.8 0.1 7.7 3.1 6.1 24.2 Green Yellow Red
2016 Confirmed measles cases Discarded Compatible Pending classification cases cases4 Total Annualized measles 1 million pop. 24.3 0.4 15.8 1382.3 7.3 0.6 126.3 6.9 30.8 3.0 4.6 7.8 102.3 50.5 5.7 94.4 3.3 1866.3 NA 4
Rash onset of Deaths due to measles last confirmed measles case 28-Dec-16 7-Aug-16 31-Dec-16 31-Dec-16 10-Dec-16 3-Jun-14 17-Dec-16 25-May-15 23-Dec-16 11-Dec-16 6-Oct-16 21-Sep-15 10-Dec-16 28-Oct-16 26-Dec-16 22-Oct-16 9-Jun-16
Country/area
Total confirmed1
Total confirmed2
Total confirmed2
Total confirmed2
millions)
3
cases
Lab
Epi-linked
confirmed incidence per 95 1 56 24 089 9 0 152 0 1 493 3 347 104 0 74 18 140 36 5 29 619 3.9 2.3 3.5 17.4 1.2 0.0 1.2 0.0 48.6 1113.3 22.8 0.0 0.7 0.4 24.6 0.4 1.5 15.9
199 1 0 6 183 8 1 228 36 1 868 0 55 0 1 536 2 40 637 5
0 0 0 507 0 1 8 129 231 110 0 0 18 3 0 156 5 1 168
0 12 663 44 819 183 11 831 374 4 625 1 185 49 46 1 484 294 92 1 171 271 56 110
0 0 0 962 1 0 5 0 151 25 567 0 0 567 0 17 332 0 27 602
87 1 56 24 046 9 0 151 0 1 468 2 811 76 0 72 18 140 36 5 28 976
8 0 0 43 0 0 1 0 25 536 28 0 2 0 0 0 0 643
0 0 0 19 0 0 0 0 1 41 0 0 0 0 2 0 0 63
13 719 70 377 193 12 998 503 6 500 30 209 153 46 2 143 315 249 1 727 278 114 435
0 10 794
Includes laboratory confirmed, epi-linked and clinically confirmed cases for 2009 to 2012. Includes laboratory confirmed and epi-linked confirmed cases from 2013 to 2016. United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects. Australia reports confirmed cases only. Classification is provisional based on laboratory data only.
<1 confirmed measles case / 1 000 000 population 1–9.9 confirmed measles case / 1 000 000 population >= 10 confirmed cases / 1 000 000 population
3
Table 4. Measles surveillance performance indicators by country and area, WHO Western Pacific Region, 2015 —2016 as of 20 January 2017 2015 Discarded nonSecond level units with ≥ 2 discarded cases per 100 000 pop [annualized]1 Suspected cases with adequate investigation Suspected cases with adequate blood specimens 1
2016 Discarded non-measles rate per 100 000 pop Second level units with ≥ 2 discarded cases per 100 000 pop [annualized]1 Suspected cases with adequate investigation Suspected cases with adequate blood specimens 2
Country/area
measles rate per 100 000 pop
≥2
≥ 80% Insufficient data Not applicable
≥ 80% Insufficient data
≥ 80% Insufficient data
≥2 Insufficient data
≥ 80% Insufficient data Not applicable
≥ 80% Insufficient data
≥ 80% Insufficient data
Australia 3 Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region 1 2
Insufficient data
4.5 4.4 4.5 2.1 1.8 0.2 8.1 12.9 52.5 0.5 1.4 1.4 0.6 1.1 2.0 6.6 4.0
100.0% 80.5% 95.0% 98.8% 100.0% Insufficient data
95.8% 98.7% 85.7% 97.7% 100.0% Insufficient data
2.8 4.2 3.2 2.5 1.8 0.7 5.4 15.0 39.4 1.1 0.6 1.5 0.6 4
100.0% 88.3% 96.8% 97.9% 100.0% Insufficient data
100.0% 99.0% 87.6% 99.5% 100.0% Insufficient data
91.7% 83.9% Not applicable Not applicable
72.0% 77.4% Not applicable Not applicable
0.0% 88.2% 87.5% 81.8% Insufficient data
4.3% 58.8% 93.8% 95.5% Insufficient data
85.4% 71.9% 7.7% Insufficient data
85.7% 82.6% 13.6% Insufficient data
99.2% 80.0% 8.0% Insufficient data
47.9% 89.1% 14.4% Insufficient data
20.0% 29.4% 0.0% Not applicable
60.8% 57.0% 68.8% 92.0% 33.2% 0.0% 78.2% Green Yellow Red
91.1% 69.7% 74.5% 19.0% 55.4% 68.6% 73.5% Reached or surpassed target
10.0% 17.6% 0.0% Not applicable
69.6% 57.3% 93.0% 85.1% 57.1% 0.0% 70.8%
95.7% 70.2% 80.6% 14.5% 78.1% 82.4% 67.6% 5
1.6 1.2 8.3 3.0
15.6% 17.4% 40.0%
22.2% 13.0% 37.9%
This indicator is not applicable for countries which have no second-level administrative units Excludes epidemiologically-linked cases. Reports only confirmed cases.
Nearly reached target: 1.00–1.99 for non- measles suspected case rate; 10.1–25% for percent clinically confirmed cases; 60–79% for other indicators Substantially below target
3 4 5
Additionally, for 38% of the notified suspected cases other specimens were collected (throat swab, nasopharyngeal swab and cerebrospinal fluid) Additionally, for 57% of the notified suspected cases other specimens were collected (throat swab and nasopharyngeal swab)
4 2
Table 5. Rubella case classification and incidence by country and area, WHO Western Pacific Region, 2015 –2016 as of 20 January 2017 2014 2015 2016 Confirmed rubella cases Country/area Rubella Rubella Population Investigated Total Total Pending Discarded Compatible incidence per incidence per 1 confirmed confirmed cases cases (in millions) rubella cases classification 1 million pop. 1 million pop. 0 30 11 887 1 0 18 226 0 343 2 0 50 2
Lab
Annualized Congenital Total rubella rubella Epi-linked confirmed incidence per syndrome 1 million pop. 0 4 3 1 3 3 67 17 2 0 0 0 0 0 18 0 0 0 0 0 0 0 0 18 0 4 4 476 3 1 3 21 67 17 2 165 3 0 307 1 5 070 0.0 0.3 3.2 0.4 1.7 0.0 3.0 2.2 5.7 0.3 1.6 0.1 0.0 3.3 0.3 2.7 Green Yellow Red Gray
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region 1 2
0.0 2.0 8.7 0.1 0.0 2.8 7.5 0.0 3.4 0.0 0.0 0.5 1.2 6.8
0 18 8 245 7 2 2 24 34 28 4 154 2 1 862 0 9 383
0.0 1.1 5.9 0.9 3.5 0.0 3.4 1.1 9.8 0.5 1.5 0.0 0.2 9.2 0.0 5.0
24.31 0.43 15.83 1 382.32 7.35 0.60 126.32 6.92 30.75 3.01 4.57 7.78 102.25 50.50 5.70 94.44 3.25 1 866.32
12 719 70 377 3 12 81 503 6 549 2 877 46 2 143 332 10 1 435 281 85 380
0 0 0 1 0 70 231 10 0 18 3 0 161 2 496
12 715 0 10 78 353 6 251 2 850 44 1 960 309 10 892 278 13 762
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
-
165 3 0 307 1 576
4 12 561
United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects. Classification is provisional based on laboratory data only.
<1 confirmed measles case / 1 000 000 population 1–9.9 confirmed measles case / 1 000 000 population >= 10 confirmed cases / 1 000 000 population No data
"-" No data
5
Table 6A. Measles and rubella laboratory testing, WHO Western Pacific Region, 2015 as of 20 February 2016 Measles Measles and rubella Serum Country/area Laboratory Total Total number number of of samples samples received tested 101 40 712 613 43 448 486 6 949 4 935 383 196 2 498 641 600 309 1 340 307 43 146 87 20 877
Serology Blood DBS samples Samples Measles tested for Measles IgM (+) IgM measles IgM equiv No. 26 33 608 540 43 82 486 5 599 4 679 157 196 2 396 397 136 305 1 304 303 43 138 49 17 520
Total number of cases tested 67 33 712 506 43 318 486 5 962 4 754 317 196 2 514 492 572 311 1 308 307 43 146 87 19 174
No. 16 4 0 13 0 14 13 1 697 1 884 8 57 641 26 12 52 134 7 7 1 15 4 601
% 61.5 12.1 0.0 2.4 0.0 17.1 2.7 30.3 40.3 5.1 29.1 26.8 6.5 8.8 17.0 10.3 2.3 16.3 0.7 30.6 26. 3
No. 1 1 0 13 2 22 13 130 442 3 18 88 23 0 10 49 3 0 2 2 822
No. received 0 0 104 0 0 0 0 0 0 0 0 59 0 0 0 0 0 0 8 38 209
No. (+) 0 9 0 4 13
Rubella Virus detection Serum and blood (includes DBS) Measles Virus Measles isolation/ Reverse Total % of Samples Rubella detection Transcription- number of samples tested for Rubella IgM (+) IgM (swab, urine and Polymerase Chain lab with rubella IgM equiv others) Reaction confirmed results ≤4 No. of No. of cases No. of days No. No. % No. samples samples No. (+) isolates tested tested 92.3 90.9 96.6 90.3 89.1 100.0 88.7 71.3 96.0 94.9 48.4 80.1 86.8 97.1 93.8 96.5 54.3 55.8 83.6
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, M acao SAR Japan Lao People's Democratic Republic M alaysia M ongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam national lab (Northern) Viet Nam national lab (Southern) Viet Nam subnational lab (Central) Viet Nam subnational lab (Highland) Fiji Vanuatu Total "-" No data
VIDRL DLS NIPH CCDC PHLC PHL NIID NCLE NPHL NCCD CHL CPHL RITM KCDC SGH NIHE PI PI IHE FCCDC FCCDC
101 40 712 613 43 409 486 6 949 4 935 383 196 2 461 641 607 309 1 340 307 43 146 87 20 808
0 0 0 7 0 0 0 881 14 1 0 51 0 143 4 36 0 0 0 0 1 137
6 50 1 0 10 0 0 0 67
76 4 0 70 0 207 0 0 266 208 0 51 245 0 4 36 5 0 0 0 1 172
69 1 15 23 135 9 20 4 0 0 0 0 0 276
63 4 0 18 0 30 13 1 722 1 956 15 57 646 28 12 52 134 7 7 1 19 4 784
2 29 712 522 43 4 479 3 791 2 875 103 43 1 793 236 303 258 1 304 304 43 124 87 13 055
1 0 18 12 1 0 20 58 36 0 4 90 10 6 8 654 13 2 0 0 933
0.0 2.5 2.3 2.3 4.2 1.5 1.3 0.0 9.3 5.0 4.2 2.0 3.1 50.2 4.3 4.7 0.0 0.0 7.1
0 0 0 0 1 0 45 42 38 1 0 85 16 0 5 31 8 1 1 0 274
6
Table 6B. Measles and rubella laboratory testing, WHO Western Pacific Region, 2016 as of 20 January 2017 Measles Measles and rubella Serum Country/area Laboratory Total Total number number of of samples samples received tested 92 16 719 600 46 1 585 175 8 579 10 031 842 40 1 612 609 813 332 842 183 77 243 15 27 451
Serology Blood DBS samples Samples Measles tested for Measles IgM (+) IgM measles IgM equiv No. 22 13 596 538 46 206 175 6 256 9 749 221 40 1 524 391 243 313 863 182 77 233 15 21 703
Total number of cases tested 67 13 719 509 46 802 175 6 593 9 996 757 40 1 610 510 724 318 866 183 77 243 15 24 263
No. 14 1 54 9 3 44 0 1 620 4 969 22 0 36 50 25 1 39 2 0 5 0 6 894
% 63.6 7.7 9.1 1.7 6.5 21.4 0.0 25.9 51.0 10.0 2.4 12.8 10.3 0.3 4.5 1.1 2.1 0.0 31. 8
No. 4 1 0 16 2 34 1 180 981 10 0 31 31 0 1 20 1 0 4 0 1 317
No. received 0 0 123 0 0 0 0 0 0 0 0 51 0 0 0 0 0 0 9 15 198
No. (+) 2 5 0 0 7
Rubella Virus detection Serum and blood (includes DBS) Measles Virus Measles isolation/ Reverse Total % of Samples Rubella detection Transcription- number of samples tested for Rubella IgM (+) IgM (swab, urine and Polymerase Chain lab with rubella IgM equiv others) Reaction confirmed results ≤4 No. of No. of cases No. of days No. No. % No. samples samples No. (+) isolates tested tested 81.3 92.3 80.9 89.0 93.0 100.0 78.6 93.6 99.8 98.2 7.5 98.9 82.4 100.0 96.1 85.2 51.1 20.8 95.1
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, M acao SAR Japan Lao People's Democratic Republic M alaysia M ongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam national lab (Northern) Viet Nam national lab (Southern) Viet Nam subnational lab (Central) Viet Nam subnational lab (Highland) Fiji Vanuatu Total "-" No data
VIDRL DLS NIPH CCDC PHLC PHL NIID NCLE NPHL NCCD CHL CPHL RITM KCDC SGH NIHE PI PI IHE FCCDC FCCDC
92 16 719 600 46 1 398 175 6 593 10 031 842 40 1 612 609 813 332 842 183 77 243 15 25 278
0 0 0 5 0 0 0 1 264 1 1 0 62 0 186 10 5 0 0 0 0 1 534
4 122 0 0 0 6 0 0 132
66 1 0 64 1 669 0 0 286 590 0 62 211 0 19 5 1 0 0 0 1 975
60 1 20 0 146 142 68 0 17 0 0 0 454
58 1 44 12 3 156 0 1 662 5 076 79 0 40 54 25 1 39 2 0 5 0 7 257
7 13 719 535 46 10 175 4 513 6 506 157 40 1 576 237 347 313 863 182 77 243 15 16 574
2 0 4 3 4 1 4 108 31 1 1 110 25 2 31 331 10 0 1 0 669
28.6 0.0 0.6 0.6 8.7 2.3 2.4 0.6 2.5 7.0 10.5 0.6 9.9 38.4 5.5 0.0 0.4 0.0 4.0
0 0 0 3 1 0 9 53 15 0 2 62 17 0 15 18 3 1 0 1 200
7
Figure 3. Measles genotype distribution of cases with rash onset in 2015 and 2016, WHO Western Pacific Region
2015
2016
B3 D4 D8 D9 The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved.
D11 G3 H1
Table 7. Measles genotype distribution of cases with rash onset in January to December 2016, WHO Western Pacific Region 2016 Country/area Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D4 D8 D9 H1 B3 D8 D9 H1 12 2 7 1 8 6 5 1 4 8 1 7 8 2 1 2 4 4 11 4 2 5 7 91 272 1 615 582 2 443 241 131 42 18 1 1 1 2 1 2 2 13 7 1 3 1 1 1 1 7 2 6 16 2 1 2 6 6 20 3 1 1 1 2 2 3 1 6 5 2 3 10 16 2 10 2 5 2 4 14 22 1 1 5 13 10 9 6 1 15 15 15 18 7 10 4 2 1 1 2 2 14 2 1 1 4 14 44 22 10 10 1 1 8
Sources: Includes all cases reported to the Western Pacific Regional Office by 20 January 2017 and the Measles Nucleotide Surveillance online database (MeaNS).
8
Figure 4. Rubella genotype distribution of cases with rash onset in 2015 and 2016, WHO Western Pacific Region
2015
2016
2B 1E
The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved.
Table 8. Rubella genotype distribution of cases with rash onset in January to December 2016, WHO Western Pacific Region Country/area Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Sources: Includes all cases reported to the Western Pacific Regional Office by 20 January 2017 and the Rubella Nucleotide Surveillance online database (RubeNS).
2016 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 1 1
9
7
26
25
14 5
5 1 4
2
2
1 1
3
2
1
1
1 5 1
1 1 1
9
Table 9A. Completeness and timeliness of epidemiologic reporting, WHO Western Pacific Region, 2014 —2016 Country Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Completeness Timeliness 1 2 3
2014 Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 92% 100% 100% 100% 100% 100% 100% 90% Timeliness 92% 100% 100% 67% 100% 100% 17% 100% 92% 100% 100% 58% 100% 100% 92% 100% 100%
2015 Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 96% Timeliness 100% 100% 100% 92% 100% 100% 92% 100% 100% 100% 100% 58% 92% 100% 100% 92% 100% Jan 04 Feb 09 Feb 10 Feb 14 Feb 05 Feb 05 Feb 06 Feb 10 Feb 05 Feb 06 Feb 09 Feb 11 Feb 11 Feb 05 Feb 02 Feb 05 Feb 10 Feb 100% 88% Feb 09 Mar 07 Mar 10 Mar 10 Mar 10 Mar 08 Mar 02 Mar 10 Mar 08 Mar 10 Mar 07 Mar 01 Apr 10 Mar 08 Mar 08 Mar 09 Mar 10 Mar 100% 94% Mar 07 Apr 07 Apr 10 Apr 12 Apr 08 Apr 05 Apr 09 Apr 10 Apr 08 Apr 09 Apr 08 Apr 10 Apr 05 Apr 07 Apr 07 Apr 07 Apr 08 Apr 100% 100% Apr 06 May 09 May 10 May 15 May 09 May 05 May 04 May 10 May 10 May 11 May 09 May 11 May 10 May 02 May 10 May 09 May 10 May 100% 82% May 06 Jun 06 Jun 10 Jun 15 Jun 10 Jun 08 Jun 10 Jun 10 Jun 10 Jun 15 Jun 10 Jun 14 Jun 08 Jun 10 Jun 10 Jun 10 Jun 10 Jun 100% 88% Jun 10 Jul 05 Jul 10 Jul 12 Jul 07 Jul 06 Jul 10 Jul 10 Jul 10 Jul 10 Jul 08 Jul 21 Jul 05 Jul 08 Jul 09 Jul 13 Jul 07 Jul 100% 88% Jul 09 Aug 06 Aug 10 Aug 15 Aug 09 Aug 03 Aug 10 Aug 10 Aug 10 Aug 08 Aug 10 Aug 10 Aug 08 Aug 10 Aug 08 Aug 10 Aug 15 Aug 100% 100%
2016 Aug 14 Sep 06 Sep 10 Sep 12 Sep 08 Sep 07 Sep 10 Sep 10 Sep 09-Sep 10 Sep 06 Sep 09 Sep 05 Sep 07 Sep 08 Sep 09 Sep 15 Sep 100% 94%
1
Sep 10 Oct 08 Oct 10 Oct 12 Oct 07 Oct 07 Oct 09 Oct 10 Oct 10 Oct 07 Oct 10 Oct 07 Oct 06 Oct 10 Oct 10 Oct 07 Oct 13 Oct 100% 100%
Oct 25 Nov 05 Nov 10 Nov 30 Nov 10 Nov 07 Nov 09 Nov 10 Nov 09 Nov 10 Nov 07 Nov 04 Nov 10 Nov 09 Nov 09 Nov 08 Nov 14 Nov 100% 88%
Nov 09 Dec 10 Dec 10 Dec 12 Dec 08 Dec 09 Dec 10 Dec 10 Dec 10 Dec 05 Dec 05 Dec 07 Dec 19 Dec 09 Dec 08 Dec 07 Dec 07 Dec 100% 94%
Dec 10 Jan 09 Jan 10 Jan 18 Jan 10 Jan 09 Jan 08 Jan 10 Jan 06 Jan 04 Jan 09 Jan 18 Jan 18 Jan 09 Jan 09 Jan 09 Jan 13 Jan 100% 82%
Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 92% 100% 100% 100% 100% 100% 100%
2
Timeliness 75% 100% 100% 83% 100% 100% 100% 100% 100% 83% 100% 50% 75% 100% 100% 92% 100%
3
92%
National measles surveillance monthly reports from December 2016. Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.
Legend: black = timely report; red = untimely report
Countries and areas should submit reports by the 10th (or the next working day) of the following month; Pacific island countries and areas and China may report to the Regional Office by the 15th (or the next working day) of the following month.
Table 9B. Completeness and timeliness of laboratory reporting, WHO Western Pacific Region, 2014 —2016 Country/area Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam national lab (Northern) Viet Nam national lab (Southern) Viet Nam subnational lab (Central) Viet Nam subnational lab (Highland) Fiji Completeness Timeliness 1 2 3
2014 Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 82% 91% 100% 99% 92% Timeliness 100% 100% 100% 100% 100% 100% 42% 100% 83% 100% 100% 92% 92% 100% 100% 83% 100% 73% 82% 100%
2015 Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 91% Timeliness 100% 100% 100% 100% 100% 100% 92% 100% 75% 75% 100% 75% 100% 100% 100% 67% 100% 67% 67% 100% Jan 04 Feb 02 Feb 10 Feb 05 Feb 05 Feb 05 Feb 06 Feb 10 Feb 12 Feb 03 Mar 09 Feb 12 Feb 05 Feb 04 Feb 05 Feb 05 Feb 02 Feb 05 Feb 05 Feb 10 Feb 100% 94% Feb 04 Mar 01 Mar 10 Mar 08 Mar 08 Mar 09 Mar 02 Mar 10 Mar 10 Mar 10 Mar 07 Mar 15 Mar 10 Mar 10 Mar 04 Mar 11 Mar 09 Mar 11 Mar 11 Mar 10 Mar 100% 80% Mar 08 Apr 06 Apr 10 Apr 08 Apr 06 Apr 05 Apr 09 Apr 10 Apr 10 Apr 10 Apr 08 Apr 10 Apr 10 Apr 08 Apr 07 Apr 12 Apr 06 Apr 10 Apr 11 Apr 08 Apr 100% 100% Apr 03 May 07 May 10 May 10 May 09 May 06 May 04 May 10 May 09 May 10 May 09 May 12 May 06 May 10 May 07 Jun 10 May 06 May 10 May 10 May 10 May 100% 95% May 02 Jun 04 Jun 10 Jun 03 Jun 07 Jun 10 Jun 10 Jun 10 Jun 14 Jun 10 Jun 10 Jun 16 May 07 Jun 10 Jun 08 Jun 06 Jun 07 Jun 06 Jun 06 Jun 10 Jun 100% 90% Jun 07 Jul 04 Jul 10 Jul 06 Jul 06 Jul 07 Jul 10 Jul 10 Jul 05 Jul 13 Jul 08-Jul 10 Aug 13 Jul 08 Jul 05 Jul 04 Jul 06 Jul 04 Jul 04 Jul 07 Jul 100% 85% Jul 03 Aug 01 Aug 10 Aug 04 Aug 05 Aug 05 Aug 10 Aug 10 Aug 09 Aug 09 Aug 10 Aug 10 Aug 08 Aug 05 Aug 08 Aug 08 Aug 09 Aug 08 Aug 08 Aug 15 Aug 100% 95%
2016 Aug 02 Sep 31 Aug 10 Sep 02 Sep 06 Sep 08 Sep 10 Sep 10 Sep 09 Sep 10 Sep 06 Sep 10 Sep 08 Sep 09 Sep 08 Sep 01 Sep 08 Sep 01 Sep 01 Sep 15 Sep 100% 100%
1
Sep 05 Oct 01 Oct 10 Oct 08 Oct 07 Oct 07 Oct 09 Oct 10 Oct 10 Oct 11 Oct 10 Oct 12 Oct 10 Oct 10 Oct 07 Oct 06 Oct 07 Oct 06 Oct 06 Oct 13 Oct 100% 90%
Oct 04 Nov 08 Nov 10 Nov 08 Nov 07 Nov 10 Nov 09 Nov 10 Nov 10 Nov 11 Nov 07 Nov 22 Nov 09 Nov 10 Nov 09 Nov 07 Nov 08 Nov 07 Nov 07 Nov 14 Nov 100% 90%
Nov 07 Dec 08 Dec 10 Dec 05 Dec 07 Dec 10 Dec 10 Dec 10 Dec 08 Dec 10 Dec 05 Dec 07 Dec 06 Dec 09 Dec 08 Dec 05 Dec 08 Dec 05 Dec 05 Dec 07 Dec 100% 100%
Dec 03 Jan 04 Jan 10 Jan 03 Jan 09 Jan 09 Jan 08 Jan 10 Jan 10 Jan 10 Jan 09 Jan 12 Jan 10 Jan 09 Jan 09 Jan 09 Jan 09 Jan 09 Jan 09 Jan 13 Jan 100% 90%
Completeness 2 100% 100% 100% 100% 100% 100% 100% 100% 100% 92% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
Timeliness 100% 100% 100% 100% 100% 100% 100% 100% 83% 67% 100% 33% 92% 100% 100% 92% 100% 92% 92% 92%
3
92%
National measles laboratory monthly reports from December 2016. Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year. National measles and rubella laboratories should submit monthly reports by the 10th (or the next working day) of the following month.
Legend: black = timely report; red = untimely report
Expanded Programme on Immunization Regional Office for the Western Pacific World Health Organization P.O. Box 2932, 1000 Manila, Philippines Tel. No. (63 2) 5288001 Fax No. (63 2) 5211036, 5260279 Please send your comments and monthly data before the 10th of the month to: WPROEPIdata@who.int
10